Among dermatologic conditions, necrotizing fasciitis (NF)—a potentially life-threatening infection of the skin and fascia—is notorious and nefarious. While it is not common in developed countries, NF has a high prevalence in undeveloped countries. Immediate treatment is essential, and thus, so is immediate and accurate diagnosis.
Study shows that adalimumab led to sustained clinical and functional responses in nearly one-third of treatment-refractory patients who completed 10 years of treatment. Patients with shorter disease duration achieved better outcomes, highlighting the need for early treatment.
Calling dermatology the study of the skin only begins to scratch the surface of the field. While environmental factors have been thoroughly looked at, advancements in technology are allowing doctors and researchers to look for deeper issues affecting their patients.
The skin disease scabies is like the television show Grey’s Anatomy: It’s been around forever, and you may, every now and again, find yourself wondering, “Is that thing still around?” In both cases, unfortunately, the answer is a definitive “yes.”
A recent review looked at the immunopathogenesis of psoriasis, identified key mediators of psoriatic plaques that are being targeted by new and emerging biologic therapies, and highlighted the latest efficacy and safety data from trials of these new agents.